Dynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns
© Walberer et al; licensee BioMed Central Ltd. 2010
Received: 27 July 2010
Accepted: 20 December 2010
Published: 20 December 2010
Neuroinflammation evolves as a multi-facetted response to focal cerebral ischemia. It involves activation of resident glia cell populations, recruitment of blood-derived leucocytes as well as humoral responses. Among these processes, phagocyte accumulation has been suggested to be a surrogate marker of neuroinflammation. We previously assessed phagocyte accumulation in human stroke by MRI. We hypothesize that phagocyte accumulation in the macrosphere model may resemble the temporal and spatial patterns observed in human stroke.
In a rat model of permanent focal ischemia by embolisation of TiO2-spheres we assessed key features of post-ischemic neuroinflammation by the means of histology, immunocytochemistry of glial activation and influx of hematogeneous cells, and quantitative PCR of TNF-α, IL-1, IL-18, and iNOS mRNA.
In the boundary zone of the infarct, a transition of ramified microglia into ameboid phagocytic microglia was accompanied by an up-regulation of MHC class II on the cells after 3 days. By day 7, a hypercellular infiltrate consisting of activated microglia and phagocytic cells formed a thick rim around the ischemic infarct core. Interestingly, in the ischemic core microglia could only be observed at day 7. TNF-α was induced rapidly within hours, IL-1β and iNOS peaked within days, and IL-18 later at around 1 week after ischemia.
The macrosphere model closely resembles the characteristical dynamics of postischemic inflammation previously observed in human stroke. We therefore suggest that the macrosphere model is highly appropriate for studying the pathophysiology of stroke in a translational approach from rodent to human.
Inflammation plays an important role in the cascade of events following cerebral ischemia that may impact on the extent of tissue damage, infarct demarcation, tissue repair und functional recovery, and may hence act as a key target for therapeutic intervention [1, 2].
Animal research has characterized postischemic inflammation as a multi-facetted response involving activation of resident glia cells and recruitment of blood-derived leucocytes as well as cascades of humoral responses [2–4]. In the classical transient middle cerebral artery occlusion (tMCAO) model, hematogeneous cells including polymorphonuclear neutrophils (PMN) and macrophages rapidly infiltrate the ischemic region [5–7].
Translating rodent research into the situation of human stroke, substantial progress has been made in visualizing aspects of postischemic inflammation in man. Starting with the first in vivo visualization of peripheral benzodiazepine receptor-expressing inflammatory cells using Positron Emission Tomography (PET) and the radiotracer [11C]PK11195 , postischemic inflammation has been repeatedly characterized by PET [8–11], magnetic resonance imaging (MRI) , and cell specific contrast agents detected by MRI [13–15]. Early histopathological descriptions suggest a significant impact of permanent versus transient ischemia on the dynamics of inflammation . Additionally, in the classical tMCAO model, tissue damage and glia activation evolve in complex spatial and temporal dynamics that make it difficult to interpret the results and to translate them into the human situation [16, 17]. Different dynamics of MRI signatures in the tMCAO model and human stroke further complicate a translational approach . Accordingly, we searched for an experimental stroke model with particular regard to the dynamics of postischemic inflammation that resembles the human situation.
In the rat macrosphere model, permanent focal ischemia is induced by intra-arterial embolization of a defined number of TiO2 spheres into the middle cerebral artery (MCA). With respect to parameters such as infarct development over time, final lesion size and clinical outcome, this model is comparable to the established pMCAO (permanent MCAO) model using an intraluminal thread [18, 19]. However, in contrast to the permanent suture model, hypothalamic injury followed by pathological hyperthermia is avoided in the macrosphere model [20, 21]. Moreover, macrosphere injection mimics arterio-arterial embolism of arteriosclerotic plaque material as the leading etiology of human stroke, while the thread occlusion model rather simulates a thromboembolic event with subsequent thrombolysis and large-vessel reperfusion . Importantly, neuroinflammation has not been described in an arterio-arterial embolic stroke model to date.
Hence, we investigated key features and dynamics of postischemic inflammation in the macrosphere model and compared our findings to the human situation as revealed by previous PET and MRI Studies.
Animals and Surgery
Histology and Immunocytochemistry
Groups of n = 3 animals each were allowed to survive for 24 hours, 3 days, and 7 days after MCA embolisation with TiO2 spheres before they were decapitated under deep anaesthesia with isoflurane. The brains were rapidly removed, frozen in 2-methylbutane, and stored at -80°C prior to further histological and immunocytochemical processing. Adjacent serial coronal brain sections were cut at 500 μm intervals (slice thickness 10 μm) and stained with hematoxylin and eosin (H&E) according to standard protocols. Anti-NeuN (clone A60, dilution 1:1000, Millipore, Billerica, USA, cat-# MAB377) was performed to recognize the DNA-binding between neuron and the specific protein NeuN, which is presented in most CNS/PNS neuronal cell types. For the identification of astrocytes, we used mAb against Glial Fibrillary Acidic Protein (GFAP) (clone GFAP, dilution 1:1000, Millipore, Billerica, USA, cat-# MAB360) and Vimentin (VIM) (dilution 1:2000, Millipore, Billerica, USA, cat-# MAB3400). The mAb against the complement receptor 3/CD11b identified microglia/macrophages (clone OX42, dilution 1:1000, AbD Serotec, Oxford, UK, cat-# MCA275R). Microglia activation was assessed by staining for MHC class II (clone Ox6, dilution 1:400, AbD Serotec, Oxford, UK, cat-#MCA46G). Phagocytic cells were identified with mAb ED1 (clone ED1, dilution 1:1000, AbD Serotec, Oxford, UK, cat-# MCA341). A double staining with anti-Iba1 (dilution 1:1000, Wako, Neuss, Germany, cat-# 019-19741) and anti-NeuN was performed additionally. Iba1 is up-regulated upon activation of microglia allowing the discrimination between resting and activated microglia. For visualization, the ABC Elite kit (Vector Laboratories, Burlingame, CA, USA) with diaminobenzidine (Sigma, Munich, Germany) or Vector SG substrate kit for peroxidase (Vector laboratories, Burlingame, CA, USA.) for anti-NeuN staining as the final reaction product was used.
To quantify phagocytic cells at day 7, the area of ED1-positive cells was measured by the analysis software Image J (1.40G, National Institutes of Health, USA) and related to the ipsilateral hemisphere.
Quantitative real-time polymerase chain reaction (PCR)
For PCR analysis, another group of animals were sacrificed 4 hours (n = 5), 24 hours (n = 5), 3 days (n = 5), and 7 days (n = 5) after ischemia induction. In addition, 4 sham-operated animals without infarct served as controls. For RNA isolation, a sample of the cortex within the infarct core (sample A) and contralateral hemisphere (sample B) were prepared along with non-ischemic cortex from control brains (Figure 1B). Approximately 30 to 50 mg tissue per tissue sample (wet weight) were obtained. Total RNA was prepared using the Trizol reagent (Gibco BRL, Gaithersburg, MD) and quantified spectrophotometrically. One microgramm RNA was reversely transcribed using oligo (dT)19 (G/A/C) primers and Superscript II reverse transcriptase (Gibco-BRL, Gaithersburg, MD) according to manufacturer's protocol. Quantitative assessment of TNF-α, IL-1β, IL-18 and iNOS gene expression levels was performed using a 7900HT Fast Real-Time PCR System (Applied Biosystems, Weiterstadt, Germany) and the Sybr Green Universal Master Mix (Applied Biosystems) and gene-specific primer pairs as described previously [23, 24]. In all PCR analyses, glyceraldehyde 3-phosphate dehydrogenase (GAPDH)  was used as the reference gene since it exhibited constant expression levels under all tested conditions. Relative gene expression levels were determined according to the manufacturer's ΔΔC t method. For quantification of PCR data, mRNA levels of the ipsilateral hemisphere were compared to levels of the contralateral hemisphere as well as to values of control animals.
The statistical analysis was performed with SigmaPlot 11 (Systat Software Inc, California, USA). Data are presented as mean ± SD. For the analysis of PCR results, two-way analysis of variance (ANOVA) with a post hoc test of Holm-Sidak was used. Statistical significance was set at the less than 5% level (p < 0.05).
Characterization of the macrosphere model
Four TiO2 spheres were injected into the ICA after ligation of the pterygopalatine artery, leading to a permanent occlusion within the ICA/MCA vessel arborisation. In all animals, one or more macrospheres directly blocked the proximal MCA (Figure 1A). H&E staining verified the infarct localization in the MCA territory of all animals (Figure 1C).
All animals showed circling behavior 24 hours after infarct induction but recovered incompletely till 72 hours. Animals in clinical distress were sacrificed, excluded from the study and replaced (n = 4).
The mean ischemic lesion volume of all animals was 161 mm3 ± 90.
The contralateral hemisphere did not show any changes in immunoreactivity at any time point (Figure 2).
Cellular inflammatory response
The contralateral hemisphere did not show changes in immunoreactivity at any time point.
Cellular interactions in the infarct demarcation zone
days after MCAO, eosinophilic coagulation necrosis (Figure 4A) and neuronal degeneration (Figure 4B) could be observed in the infarct core. ED1+ phagocytes (Figure 4C) and activated microglia (Figure 4D, brown) accumulated at the infarct border and interacted with neurons (Figure 4D, red arrows). Astrocytic activation (protoplasmic astrocytes) was clearly visible at the border of the infarct, but not in the infarct core. A demarcation of a scar-like formation could be observed at the periphery of the infarct core (Figure 4E, F) and vimentin immunoreactivity depicted immature astrocytes indicating proliferation of astrocytes.
In the macrosphere model, the intra-arterial injection of 4 TiO2 spheres leads to permanent occlusion of the MCA resulting in an ischemic lesion of the MCA-territory . The interindividual variability of infarct volume caused by different occlusion sites of the macrospheres is similar to other embolic stroke models. This technique mimics arterio-arterial embolism of "hard" atherosclerotic plaque material, the most frequent cause of stroke in humans [22, 25]. Moreover, in contrast to the well-established suture model of permanent ischemia, the macrosphere model avoids hypothalamic injury and subsequently hyperthermia [18, 20, 21], while hypothalamic infarction is extremely rare in patients. Hyperthermia may be a confounding factor in therapeutic studies and may influence CNS inflammatory responses as well. In those regards, the macrosphere model offers clear advantages compared to the commonly used transient and permanent suture models, and has therefore been suggested to represent a clinically relevant model to study the pathophysiology of stroke.
In a proof-of-principles study we previously visualized macrophage infiltration in human stroke by a superparamagnetic iron oxide contrast agent (USPIO) . At 3-4 days after stroke onset, we detected subtle contrast enhancement in only a minority of patients. However, 6-8 days after onset of ischemia, we consistently found signs of macrophage infiltration in subcortical as well as cortical areas. Macrophage infiltration heterogeneously affected subregions of the infarct with significant inter-individual differences. This is in accordance with the dynamics of cellular responses after permanent focal ischemia in primates reported earlier . Going back from "bedside to bench", two essential features of cellular responses in the macrosphere model are reminiscent of the human situation: (i) the slowly evolving macrophage infiltration at the end of the first post-infarct week, and (ii) the heterogeneous distribution of the macrophage infiltrate throughout the infarct.
In rodent models of tMCAO, the temporal evolution of tissue damage has also been shown to be heterogeneously, extending in distinct patterns on a subcortical to cortical axis, which renders inflammatory responses complex and difficult to assess [16, 17]. Reperfusion accelerates inflammation, facilitating the rapid infiltration of hematogeneous cells, to an early and diffuse accumulation of PMNs throughout the infarct [5–7, 27].
In contrast, rodent models of permanent MCAO show rapid signs of tissue damage evolving in the infarct core and succumbing to necrosis, while more peripheral areas display a greater variability in the severity of ischemia. After pMCAO, peripheral areas are usually associated with incomplete necrosis, while subcortical regions show only mild ischemic neuronal damage without loss of neurons . In a rat model of pMCAO, direct surgical occlusion of the MCA led to an accumulation of PMN leukocytes with a maximum at 48-72 hours , which is just as late as the PMN infiltration seen after human stroke . In a monkey model of pMCAO, PMNs within the reactive zone could be observed in modest numbers at 18 hours, and increased to 72 hours, while seven-day old lesion showed PMNs in the central infarcted zone only . By comparing permanent and transient MCAO in spontaneously hypertensive rats, the infiltration of neutrophils was moderate in pMCAO. Furthermore, the activity of the neutrophil marker myeloperoxidase was 2 to 3-fold increased, depending of the reperfusion time in tMCAO compared to pMCAO within the first day . Those previous studies suggest that pMCAO models reflect the dynamics of human postischemic inflammation much better than tMCAO models do.
In this study, the extent of ischemic damage obtained by macrosphere embolization corresponded to previous experiments and was comparable to other pMCAO models [18–21]. In contrast, our pMCAO model was different from the previously described photochemically induced focal ischemia model that produces only a pure neocortical infarction [29, 30]. While the infarcted area underwent necrosis, the surrounding tissue displayed an increasing astrocyte reactivity over time as revealed by GFAP-staining, a phenomenon that was similar to photothrombosis [30, 31]. With respect to the cellular inflammatory response, we observed a transition of ramified into ameboid phagocytic microglia in the boundary zone of the infarct, with consecutive infarct demarcation as late as three days after the induction of ischemia, corresponding to the situation after photothrombosis  as well as to that after human stroke . Stoll et al. observed the accumulation of phagocytes in the border zone of human infarcts after 5 days . This combined microglia/macrophage response was accompanied by an up-regulation of MHC class II molecules. In the ischemic core, morphological signs of microglia activation could be detected by day 7, but not at day 1, similar to the photothrombosis model [17, 30, 32, 33]. In human PET studies using the peripheral benzodiazepine ligand [11C]PK11195 as a surrogate marker for inflammation to investigate the temporo-spatial profile of microglia-activation and macrophage-invasion [34–36] and MRI studies using ultrasmall supermagnetic iron oxide (USPIO) to study the invasion of blood-borne macrophages into human brain [12, 37], microglia activation in human stroke have been detected to start as late as 3 days after onset of ischemia and reached its maximum within one week [12, 34–37]. Interestingly, in the macrosphere model activated microglia and macrophages established a particularly dense cellular wall around the infarct core after 7 days, whereas reactive astrocytes had formed a ring already by day 3, similar to the situation observed in the photothrombosis model [29, 31]. The time-course of cytokine release in the macrosphere model differed slightly from the situation in the photothrombosis model. While we found a rapid induction of TNF-α similar to photothrombosis, a much later upregulation of IL-1β and iNOS occurred peaking at day 3. TNF-α and IL-1β are synthesized by PMNs  and therefore PMN accumulation may contribute to TNF-α and IL-1β production-besides resident microglia as a principle source-peaking at 72 hours. The induction of IL-18 occurred even later and increased up to day 7. This late induction of IL-18 is in good accordance with the situation previously observed in the photothrombosis model, where the maximum upregulation was found at day 14, a time point not included in our present study .
Activation of microglia (maximum)
day 3 (day 7)
day 3 (day 7)37
6 h (day 3)17
Transformation from ramified to ameboid microglia in the infarct border
from day 3 on
Infiltration of macrophages/microglia in the infarct core
day 6- day 814
Spatial patterns of macrophages/microglia accumulation
"wall-like" accumulation in the outer infarct, sparing the infarct core
"wall-like" accumulation in the outer infarct, sparing the infarct core14
heterogeneous, extending in distinct patterns on a subcortical to cortical axis17
Accumulation of phagozytes
The macrosphere model as a model of focal cerebral ischemia resembles closely the dynamics of human postischemic inflammation, imitating particularly the slow time course of human neuroinflammation. Therefore we suggest that the macrosphere model mimics the clinical situation of human stroke better than the commonly used model of transient middle cerebral artery occlusion. Accordingly the rodent macrosphere model is regarded most relevant for studying the pathophysiology of stroke and possesses high clinical relevance.
GRF was supported by a grant from the Federal Ministry of Education and Research, Germany: "Brain Imaging Center West" (No. 01 GO 0517).
We thank Birgit Blomenkamp for expert technical assistance for the PCR experiments.
- Becker KJ: Targeting the central nervous system inflammatory response in ischemic stroke. Curr Opin Neurol 2001, 14: 349–353. 10.1097/00019052-200106000-00014PubMedView ArticleGoogle Scholar
- Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22: 391–397. 10.1016/S0166-2236(99)01401-0PubMedView ArticleGoogle Scholar
- Arvin B, Neville LF, Barone FC, Feuerstein GZ: The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996, 20: 445–452. 10.1016/0149-7634(95)00026-7PubMedView ArticleGoogle Scholar
- Stoll G, Jander S, Schroeter M: Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998, 56: 149–171. 10.1016/S0301-0082(98)00034-3PubMedView ArticleGoogle Scholar
- Ames A, Wright RL, Kowada M, Thurston JM, Majno G: Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 1968, 52: 437–453.PubMed CentralPubMedGoogle Scholar
- Clark RK, Lee EV, White RF, Jonak ZL, Feuerstein GZ, Barone FC: Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 1994, 35: 387–392. 10.1016/0361-9230(94)90119-8PubMedView ArticleGoogle Scholar
- Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992, 23: 1367–1379.PubMedView ArticleGoogle Scholar
- Ramsay SC, Weiller C, Myers R, Cremer JE, Luthra SK, Lammertsma AA, Frackowiak RS: Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet 1992, 339: 1054–1055. 10.1016/0140-6736(92)90576-OPubMedView ArticleGoogle Scholar
- Enblad P, Frykholm P, Valtysson J, Silander HC, Andersson J, Fasth KJ, Watanabe Y, Långström B, Hillered L, Persson L: Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke 2001, 32: 1574–1580.PubMedView ArticleGoogle Scholar
- Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barré L, Travère JM, Derlon JM, MacKenzie ET: In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 1993, 24: 2046–2057.PubMedView ArticleGoogle Scholar
- Schroeter M, Dennin MA, Walberer M, Backes H, Neumaier B, Fink GR, Graf R: Neuroinflammation extends brain tissue at risk to vital peri-infarct tissue: a double tracer [(11)C]PK11195- and [(18)F]FDG-PET study. J Cereb Blood Flow 2009, 29: 1216–1225. 10.1038/jcbfm.2009.36View ArticleGoogle Scholar
- Schroeter M, Franke C, Stoll G, Hoehn M: Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain. Acta Neuropathol 2001, 101: 114–122.PubMedGoogle Scholar
- Breckwoldt MO, Chen JW, Stangenberg L, Aikawa E, Rodriguez E, Qiu S, Moskowitz MA, Weissleder R: Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci USA 2008, 105: 18584–18589. 10.1073/pnas.0803945105PubMed CentralPubMedView ArticleGoogle Scholar
- Jander S, Schroeter M, Saleh A: Imaging inflammation in acute brain ischemia. Stroke 2007, 38: 642–645. 10.1161/01.STR.0000250048.42916.adPubMedView ArticleGoogle Scholar
- Jiang Q, Chopp M, Zhang ZG, Knight RA, Jacobs M, Windham JP, Peck D, Ewing JR, Welch KM: The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat. J Neurol Sci 1997, 145: 15–23. 10.1016/S0022-510X(96)00286-9PubMedView ArticleGoogle Scholar
- Garcia JH, Kamijyo Y: Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol 1974, 33: 408–421. 10.1097/00005072-197407000-00007PubMedView ArticleGoogle Scholar
- Lehrmann E, Christensen T, Zimmer J, Diemer NH, Finsen B: Microglial and macrophage reactions mark progressive changes and define the penumbra in the rat neocortex and striatum after transient middle cerebral artery occlusion. J Comp Neurol 1997, 386: 461–476. 10.1002/(SICI)1096-9861(19970929)386:3<461::AID-CNE9>3.0.CO;2-#PubMedView ArticleGoogle Scholar
- Gerriets T, Stolz E, Walberer M, Muller C, Rottger C, Kluge A, Kaps M, Fisher M, Bachmann G: Complications and pitfalls in rat stroke models for middle cerebral artery occlusion: a comparison between the suture and the macrosphere model using magnetic resonance imaging. Stroke 2004, 35: 2372–2377. 10.1161/01.STR.0000142134.37512.a7PubMedView ArticleGoogle Scholar
- Gerriets T, Stolz E, Walberer M, Müller C, Kluge A, Kaps M, Fisher M, Bachmann G: Middle cerebral artery occlusion during MR-imaging: investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res Brain Res Protoc 2004, 12: 137–143. 10.1016/j.brainresprot.2003.08.006PubMedView ArticleGoogle Scholar
- Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, Fisher M: The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods 2003, 122: 201–211. 10.1016/S0165-0270(02)00322-9PubMedView ArticleGoogle Scholar
- Gerriets T, Stolz E, Walberer M, Kaps M, Bachmann G, Fisher M: Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance. Stroke 2003, 34: 234–2239. 10.1161/01.STR.0000087171.34637.A9View ArticleGoogle Scholar
- Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC: Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001, 32: 2559–2566. 10.1161/hs1101.098524PubMedView ArticleGoogle Scholar
- Jander S, Schroeter M, Stoll G: Interleukin-18 expression after focal ischemia of the rat brain: Association with late-stage inflammatory response. J Cereb Blood Flow Metab 2002, 22: 62–70. 10.1097/00004647-200201000-00008PubMedView ArticleGoogle Scholar
- Schroeter M, Küry P, Jander S: Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Brain Res Mol Brain Res 2003, 117: 1–7. 10.1016/S0169-328X(03)00255-9PubMedView ArticleGoogle Scholar
- Stroke Therapy Academic Industry Roundtable: Recommendations for standards regarding preclinical neuroprotective and restorative drugs. Stroke 1999, 30: 2752–2758.View ArticleGoogle Scholar
- Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ: Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994, 144: 188–199.PubMed CentralPubMedGoogle Scholar
- Barone FC, Schmidt DB, Hillegass LM, Price WJ, White RF, Feuerstein GZ, Clark RK, Lee EV, Griswold DE, Sarau HM: Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke 1992, 23: 1337–1347.PubMedView ArticleGoogle Scholar
- Dereski MO, Chopp M, Knight RA, Rodolosi LC, Garcia JH: The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat. Acta Neuropathol 1993, 85: 327–333. 10.1007/BF00227730PubMedView ArticleGoogle Scholar
- Schroeter M, Jander S, Witte OW, Stoll G: Heterogeneity of the microglial response in photochemically induced focal ischemia of the rat cerebral cortex. Neuroscience 1999, 89: 1367–1377. 10.1016/S0306-4522(98)00398-4PubMedView ArticleGoogle Scholar
- Schroeter M, Schiene K, Kraemer M, Hagemann G, Weigel H, Eysel UT, Witte OW, Stoll G: Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp Brain Res 1995, 106: 1–6. 10.1007/BF00241351PubMedView ArticleGoogle Scholar
- Nowicka D, Rogozinska K, Aleksy M, Witte OW, Skangiel-Kramska J: Spatiotemporal dynamics of astroglial and microglial responses after photothrombotic stroke in the rat brain. Acta Neurobiol Exp (Wars) 2008, 68: 155–168.Google Scholar
- Morioka T, Kalehua AN, Streit WJ: Characterization of microglia reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol 1993, 327: 123–132. 10.1002/cne.903270110PubMedView ArticleGoogle Scholar
- Zhang Z, Chopp M, Powers C: Temporal profile of microglia response following transient (2h) middle cerebral artery occlusion. Brain Res 1997, 744: 189–198. 10.1016/S0006-8993(96)01085-2PubMedView ArticleGoogle Scholar
- Gerhard A, Neumaier B, Elitok E, Glatting G, Ries V, Tomczak R, Ludolph AC, Reske SN: In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport 2000, 11: 2957–2960. 10.1097/00001756-200009110-00025PubMedView ArticleGoogle Scholar
- Gerhard A, Schwarz J, Myers R, Wise R, Banati RB: Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage 2005, 24: 591–595. 10.1016/j.neuroimage.2004.09.034PubMedView ArticleGoogle Scholar
- Price CJ, Wang D, Menon DK, Guadagno JV, Cleij M, Fryer T, Aigbirhio F, Baron JC, Warburton EA: Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke 2006, 37: 1749–1753. 10.1161/01.STR.0000226980.95389.0bPubMedView ArticleGoogle Scholar
- Saleh A, Schroeter M, Ringelstein A, Hartung HP, Siebler M, Mödder U, Jander S: Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke 2007, 10: 2733–2737. 10.1161/STROKEAHA.107.481788View ArticleGoogle Scholar
- Feuerstein GZ, Wang X, Barone FC: The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 1998, 5: 143–59. 10.1159/000026331PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.